Generate a tailored SOP for Dr. Robbert Hoogeboom. Improve your application with a focused, well-structured draft.
Robbert Hoogeboom is a lecturer at King's College London, specializing in lymphoma research. He obtained his PhD from the Academic Medical Centre in Amsterdam, Netherlands, and subsequently served as a postdoctoral researcher at the National Institute for Medical Research and The Francis Crick Institute. In 2018, he joined King's College London, where he leads a research group that focuses on the role of antigen exposure and B cell receptor signaling in the pathogenesis and treatment of B cell leukemia and lymphoma. His team employs high content imaging of primary patient cells and novel in vivo mouse models to investigate how malignant B cells respond to antigen stimulation and the influence this has on tumor cell behavior and disease progression. Dr. Hoogeboom has contributed to various published research articles and chapters that explore areas such as cancer signaling, antibody responses, and cellular mechanisms associated with B cell malignancies.
Requirements are consistent across King's Business School and Social Science & Public Policy departments for standard Master's entries.